Vienna session organised by a 'priority setting partnership' for infertility unveils ten priorities for research in the four key areas: male infertility, female and unexplained infertility, assisted reproduction and the ethics of treatment.

Substantial heterogeneity exists in the reporting of outcomes of fertility trials, with inconsistencies in numerators, denominators and definitions making results difficult to interpret, compare and combine in meta-analyses. Jack Wilkinson presented the rationale for a core outcome set of measures for fertility trials on behalf of the Cochrane Gynaecology and Fertility Group and the COMMIT initiative in Vienna.

The benefits are being exaggerated and the costs underestimated by those promoting aneuploidy testing to clinics and patients. An exchange session with the ASRM urges caution.

Professor Rick Legro, a tireless advocate of randomised trials, talks to Focus on Reproduction about the general quality of evidence in reproductive medicine today - but with a particular reference to the latest international guidelines on PCOS.

Minutes of the Annual Assembly of Members, held on Tuesday 25 June 2019, 18.00, at Messe Wien, Vienna, Austria

Conventional semen analysis according to WHO manual parameters is limited, with no consideration of testis function or sperm quality. Madelon Van Wely of the Academic Medical Centre University of Amsterdam reviewed current evidence in support of sperm DNA fragmentation testing in ART.

Goodbye to PR per ET? Professor Cindy Farquhar from the Cochrane Fertility & Gynecology group on plans to improve the quality of evidence in reproductive medicine and introduce core outcome measures of live birth in adequately powered studies.

It's now 20 years since ESHRE European IVF Monitoring (EIM) Consortium was founded, with activity data for 1997 as its first publication. Since then the Consortium's annual reports have been some of the most widely cited in Human Reproduction, and today providing more than a mere snapshot of what's going on. In Vienna Christine Wyns, head of gynecology and andrology at the Cliniques Universitaires Saint-Luc and Professor at the Catholic University of Louvain in Brussels, took over as Chair of the Consortium.

There is now a long catalogue of inconclusive studies investigating an association between ART and risk of ovarian cancer. A large-scale multicentre analysis reported in Vienna concluded that nulliparity rather than ART is the likely explanation for any link. Results were described as 'reassuring'.

Fertility as much as any other discipline in medicine is subject to over-exaggerated claims of popular reporting. Scientists should take care how they present their data.